Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SOLTOX
- Development stage
- Preclinical
- Lead developer
- CELSET
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intradermal, Intramuscular, Subcutaneous
01
Overview
SOLTOX is a botulinum toxin type A product developed by CELSET, a South Korean biotechnology company specializing in medical aesthetics. Launched in October 2026 for international markets, SOLTOX is a biologic protein neurotoxin complex characterized by a 900 kDa toxin complex, a freeze-dried (lyophilized) dosage form, and an advanced purification process. It is supplied in 100 Unit and 200 Unit presentations as a lyophilized powder intended for reconstitution before administration by qualified medical professionals. SOLTOX is positioned for the medical aesthetics market, where it acts as a neuromuscular blocking agent by targeting synaptic vesicle glycoprotein 2A (SV2A) and cleaving synaptosome-associated protein 25 (SNAP-25), thereby inhibiting the release of acetylcholine at the neuromuscular junction and causing temporary muscle relaxation.
- Brand names
- SOLTOX
- Other names
- botulinum toxin type A
02
Targets
SV2A (Synaptic vesicle glycoprotein 2A)SNAP25 (Synaptosome-associated protein 25)
Beyond the preview
Go deeper on SOLTOX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SOLTOX.